Impact of Shocks on Mortality in Patients with Ischemic or Dilated Cardiomyopathy and Defibrillators Implanted for Primary Prevention

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Streitner, Florian ^a   Herrmann, Thomas ^a   Kuschyk, Juergen ^a   Lang, Siegfried ^a   Doesch, Christina ^a   Papavassiliu, Theano ^a   Streitner, Ines ^a   Veltmann, Christian ^a   Haghi, Dariusch ^a   Borggrefe, Martin ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COMPARATIVE EFFECTIVENESS; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DEVICE THERAPY; DISEASE CONTROL; FEMALE; FOLLOW UP; HEART PROTECTION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIMARY PREVENTION; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; THERAPY EFFECT; TREATMENT RESPONSE; TREND STUDY;

AGE FACTORS; AGED; CARDIOMYOPATHY, DILATED; CAUSE OF DEATH; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROGNOSIS; SEX FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 84877608466     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063911     Document Type: Article

References (16)

1. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, et al. (2000) Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 21: 2071-2078.
2. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, et al. (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346: 877-883.
3. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, et al. (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352: 225-237.
4. Sweeney MO, (2010) The contradiction of appropriate shocks in primary prevention ICDs: increasing and decreasing the risk of death. Circulation 122: 2638-2641.
5. Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, et al. (2004) Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 110: 3760-3765.
6. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, et al. (2008) Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359: 1009-1017.
7. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, et al. (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 117: e350-408.
8. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, et al. (2006) ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J 27: 2099-2140.
9. Packer DL, Prutkin JM, Hellkamp AS, Mitchell LB, Bernstein RC, et al. (2009) Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial. Circulation 120: 2170-2176.
10. Dichtl W, Wolber T, Paoli U, Brullmann S, Stuhlinger M, et al. (2011) Appropriate therapy but not inappropriate shocks predict survival in implantable cardioverter defibrillator patients. Clin Cardiol 34: 433-436.
11. Dorian P, Hohnloser SH, Thorpe KE, Roberts RS, Kuck KH, et al. (2010) Mechanisms underlying the lack of effect of implantable cardioverter-defibrillator therapy on mortality in high-risk patients with recent myocardial infarction: insights from the Defibrillation in Acute Myocardial Infarction Trial (DINAMIT). Circulation 122: 2645-2652.
12. Steinbeck G, Andresen D, Seidl K, Brachmann J, Hoffmann E, et al. (2009) Defibrillator implantation early after myocardial infarction. N Engl J Med 361: 1427-1436.
13. Kelly P, Ruskin JN, Vlahakes GJ, Buckley MJ Jr, Freeman CS, et al. (1990) Surgical coronary revascularization in survivors of prehospital cardiac arrest: its effect on inducible ventricular arrhythmias and long-term survival. J Am Coll Cardiol 15: 267-273.
14. Wathen M, (2007) Implantable cardioverter defibrillator shock reduction using new antitachycardia pacing therapies. Am Heart J 153: 44-52.
15. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, et al. (2004) Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation 110: 2591-2596.
16. Sweeney MO, Sherfesee L, DeGroot PJ, Wathen MS, Wilkoff BL, (2010) Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. Heart Rhythm 7: 353-360.